Dr. Deepti A. Munjal, MD

Dr. Munjal practices at Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital.

Dr. Munjal's NPI, 1922086610, was assigned on January 4, 2006. Dr. Munjal holds Georgia license 046627.

Dr. Munjal's primary practice is Northside Hospital Atlanta, at 1000 Johnson Ferry Road, NE, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 851-8000.

Dr. Munjal's primary practice is Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital. Dr. Munjal is also affiliated with Wellstar Kennestone Regional Medical Center. The medical group on file is Northside Hospital Cancer Institute. Dmand AI also links Dr. Munjal to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Munjal practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Munjal's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Munjal is licensed in Georgia.

CMS data shows 203 Medicare services from Dr. Munjal across 2 procedure codes in 2024, all of them office visits, for 105 Medicare patients. Medicare paid $11,782 for them. Every service was in an office.

CMS counts 105 Medicare patients who saw Dr. Munjal in 2024. The largest group is 65 to 74, with 50 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Munjal's median patient age at 67, with 69% women.

In 2024, Dr. Munjal wrote 757 Medicare Part D claims for 162 patients. 79% of them were for generic drugs. CMS names the drug for 548 of them, across 20 drugs with 11 or more claims each, at $376,747 in total drug cost. In 2023, CMS named 1,006 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 71 out of 100 for Dr. Munjal for performance year 2024, reported as part of a group. Dr. Munjal accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 62 general payments to Dr. Munjal from 33 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Celgene Corporation paid the most, $176.